MUC1 and neoplasm: Immunization with the multicomponent vaccine led to significant reductions in tumor burden and weight when compared with treatment using either empty liposomes or immunization with a control vaccine that didn’t contain the MUC1 glycopeptide epitope or an unglycosylated multicomponent candidate.